Total Payments
$7,918
2024 Payments
$458.93
Companies
22
Transactions
114
Medicare Patients
4,744
Medicare Billing
$448,720
Payment Breakdown by Category
Food & Beverage$5,133 (64.8%)
Consulting$1,950 (24.6%)
Travel$772.80 (9.8%)
Education$62.92 (0.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,133 | 104 | 64.8% |
| Consulting Fee | $1,950 | 1 | 24.6% |
| Travel and Lodging | $772.80 | 6 | 9.8% |
| Education | $62.92 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,989 | 2 | $0 (2022) |
| Allergan, Inc. | $1,305 | 21 | $0 (2022) |
| Valeant Pharmaceuticals North America LLC | $1,079 | 15 | $0 (2017) |
| Alcon Vision LLC | $685.79 | 10 | $0 (2024) |
| ABBVIE INC. | $521.54 | 14 | $0 (2024) |
| Sight Sciences, Inc. | $421.33 | 16 | $0 (2024) |
| Glaukos Corporation | $324.11 | 7 | $0 (2023) |
| Aerie Pharmaceuticals, Inc. | $293.80 | 6 | $0 (2021) |
| Alcon Laboratories Inc | $219.69 | 3 | $0 (2018) |
| NEW WORLD MEDICAL,INC. | $155.00 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $458.93 | 14 | ABBVIE INC. ($248.93) |
| 2023 | $592.99 | 10 | Alcon Vision LLC ($379.08) |
| 2022 | $940.62 | 32 | GLAUKOS CORPORATION ($239.99) |
| 2021 | $2,844 | 21 | GlaxoSmithKline, LLC. ($1,950) |
| 2020 | $383.86 | 7 | Allergan, Inc. ($192.36) |
| 2019 | $628.99 | 5 | Alcon Vision LLC ($167.67) |
| 2018 | $782.53 | 8 | Allergan Inc. ($248.95) |
| 2017 | $1,287 | 17 | Valeant Pharmaceuticals North America LLC ($1,079) |
All Payment Transactions
114 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Ophthalmology | ||||||
| 11/14/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: OPTOMETRY | ||||||
| 11/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: EYE CARE | ||||||
| 09/23/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Ophthalmology | ||||||
| 09/16/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: EYE CARE | ||||||
| 07/23/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $32.84 | General |
| Category: Ophthalmology | ||||||
| 05/06/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Dry eyes | ||||||
| 05/02/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Ophthalmology | ||||||
| 03/18/2024 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Ophthalmology | ||||||
| 03/03/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $123.52 | General |
| Category: EYE CARE | ||||||
| 02/27/2024 | Sight Sciences, Inc. | TEARCARE SYSTEM (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Ophthalmology | ||||||
| 02/23/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $33.62 | General |
| Category: EYE CARE | ||||||
| 02/07/2024 | Thea Pharma Inc. | IYUZEH (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/17/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: EYE CARE | ||||||
| 12/08/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Ophthalmology | ||||||
| 10/30/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $35.54 | General |
| Category: Ophthalmology | ||||||
| 10/17/2023 | AbbVie Inc. | LUMIGAN (Drug), ALPHAGAN P | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: EYE CARE | ||||||
| 10/03/2023 | AbbVie Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $35.52 | General |
| Category: EYE CARE | ||||||
| 08/08/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $36.02 | General |
| 06/26/2023 | Johnson & Johnson Surgical Vision, Inc. | Tecnis IOL (Device) | Food and Beverage | In-kind items and services | $29.83 | General |
| Category: Optics | ||||||
| 05/12/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $31.20 | General |
| Category: DRY EYE | ||||||
| 04/01/2023 | Alcon Vision LLC | — | Food and Beverage | In-kind items and services | $310.15 | General |
| 03/06/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $33.39 | General |
| Category: Ophthalmology | ||||||
| 01/12/2023 | AbbVie Inc. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $30.69 | General |
| Category: EYE CARE | ||||||
| 12/15/2022 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $30.36 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,262 | 1,824 | $227,066 | $162,394 |
| 2022 | 15 | 1,197 | 1,596 | $221,079 | $158,786 |
| 2021 | 15 | 1,244 | 1,404 | $238,655 | $80,691 |
| 2020 | 13 | 1,041 | 1,206 | $267,631 | $46,850 |
Total Patients
4,744
Total Services
6,030
Medicare Billing
$448,720
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 344 | 670 | $95,168 | $67,604 | 71.0% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 45 | 69 | $41,187 | $28,670 | 69.6% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 15 | 20 | $16,248 | $11,745 | 72.3% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 95 | 95 | $15,889 | $10,920 | 68.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 24 | 31 | $11,642 | $9,042 | 77.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 133 | 145 | $10,375 | $7,603 | 73.3% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2023 | 21 | 35 | $9,500 | $7,035 | 74.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 119 | 129 | $5,320 | $3,644 | 68.5% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 120 | 233 | $3,954 | $3,021 | 76.4% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 56 | 84 | $3,845 | $2,690 | 70.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 29 | 33 | $3,354 | $2,629 | 78.4% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 93 | 109 | $3,349 | $2,489 | 74.3% |
| 92250 | Photography of the retina | Office | 2023 | 62 | 63 | $2,649 | $1,975 | 74.6% |
| 92134 | Imaging of retina | Office | 2023 | 46 | 48 | $2,172 | $1,568 | 72.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $1,825 | $1,320 | 72.3% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 47 | 47 | $590.69 | $436.79 | 73.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 262 | 505 | $72,660 | $51,809 | 71.3% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 45 | 68 | $40,774 | $29,530 | 72.4% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2022 | 26 | 34 | $27,897 | $19,724 | 70.7% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 114 | 114 | $19,382 | $13,104 | 67.6% |
| 65855 | Laser repair to improve eye fluid flow | Office | 2022 | 31 | 50 | $14,047 | $10,781 | 76.8% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2022 | 24 | 31 | $11,712 | $9,014 | 77.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 104 | 114 | $8,246 | $5,991 | 72.7% |
| 92133 | Imaging of optic nerve | Office | 2022 | 121 | 127 | $5,324 | $3,881 | 72.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 54 | 58 | $5,908 | $3,879 | 65.7% |
About Dr. Igor Bussel, MD
Dr. Igor Bussel, MD is a Glaucoma Specialist healthcare provider based in Fullerton, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2014. The National Provider Identifier (NPI) number assigned to this provider is 1699193367.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Igor Bussel, MD has received a total of $7,918 in payments from pharmaceutical and medical device companies, with $458.93 received in 2024. These payments were reported across 114 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($5,133).
As a Medicare-enrolled provider, Bussel has provided services to 4,744 Medicare beneficiaries, totaling 6,030 services with total Medicare billing of $448,720. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Glaucoma Specialist
- Location Fullerton, CA
- Active Since 03/31/2014
- Last Updated 11/03/2022
- Taxonomy Code 207WX0009X
- Entity Type Individual
- NPI Number 1699193367
Products in Payments
- BLENREP (Biological) $1,950
- STELLARIS PC (Device) $1,079
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $704.70
- XEN (Device) $566.32
- AcrySof (Device) $267.71
- ISTENT INJECT W (Device) $239.99
- OMNI(R) SURGICAL SYSTEM (US) (Device) $231.26
- rocklatan (Drug) $211.29
- DURYSTA (Drug) $156.86
- Ahmed Glaucoma Valve (Device) $155.00
- Hydrus Microstent (Device) $139.55
- OMNI (Device) $133.33
- ACTHAR (Biological) $122.78
- LUMIGAN (Drug) $115.07
- Lucentis (Biological) $104.96
- Clareon (Device) $99.24
- Cequa (Drug) $84.43
- Rhopressa (Drug) $83.93
- CyPass (Device) $76.16
- VUITY (Drug) $75.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.